Use of Continuous Glucose Monitoring and Glucagon-Like Peptide 1 Receptor Agonist Therapy to Achieve Individualized Treatment Goals in Insulin-Treated People With Type 2 Diabetes: A Case Series and Expert Opinion.
- Resource Type
- Case Study
- Source
Clinical Diabetes . Spring2024, Vol. 42 Issue 2, p341-350. 10p.- Subject
- *
INSULIN therapy
*GLUCAGON-like peptide-1 agonists
*METFORMIN
*WEIGHT loss
*CARDIOVASCULAR diseases
*TREATMENT effectiveness
*RAPID diagnostic tests
*HYPOGLYCEMIC agents
*HYPERGLYCEMIA
*CONTINUOUS glucose monitoring
*TYPE 2 diabetes
*INDIVIDUALIZED medicine
*HYPOGLYCEMIA
*DISEASE complications - Language
- ISSN
- 0891-8929